Ari Ristimäki
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms 2
- Cancer-related molecular mechanisms research 2
- Oncology top 10%
- Peptidase Inhibition and Analysis 2
- Immunology and Allergy top 10%
-
- RNA modifications and cancer 2
- Glycosylation and Glycoproteins Research 1
-
- Inflammatory mediators and NSAID effects 3
-
- Estrogen and related hormone effects 2
- Virus-based gene therapy research 1
Ari Ristimäki
12 papers receiving 765 citations
Peers
Comparison fields: 5 of 73
- Cancer Research 229
- Oncology 328
- Immunology and Allergy 43
- Molecular Biology 470
- Hematology 48
Countries citing papers authored by Ari Ristimäki
This map shows the geographic impact of Ari Ristimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ari Ristimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ari Ristimäki more than expected).
Fields of papers citing papers by Ari Ristimäki
This network shows the impact of papers produced by Ari Ristimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ari Ristimäki. The network helps show where Ari Ristimäki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ari Ristimäki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 83 | |
| 2 | [Changing prognosis and treatment of gastric cancer]. | 2010 | 0 |
| 3 | 2010 | 11 | |
| 4 | 2010 | 2 | |
| 5 | 2009 | 1 | |
| 6 | 2009 | 48 | |
| 7 | Mmp-8 expression in females correlates with the improved survival of tongue cancer | 2006 | 1 |
| 8 | 2006 | 48 | |
| 9 | 2006 | 66 | |
| 10 | 2001 | 27 | |
| 11 | 1997 | 379 | |
| 12 | Tumor-associated trypsin participates in cancer cell-mediated degradation of extracellular matrix. | 1991 | 93 |
| 13 | Monoclonal antibodies reacting with placental protein 5: use in radioimmunoassay, Western blot analysis, and immunohistochemistry. | 1988 | 21 |
About Ari Ristimäki
Ari Ristimäki is a scholar working on Cancer Research, Pharmacology, Immunology and Allergy, Oncology and Reproductive Medicine, having authored 13 papers that have together received 780 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (3 papers), RNA modifications and cancer (2 papers), Estrogen and related hormone effects (2 papers), Peptidase Inhibition and Analysis (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer-related molecular mechanisms research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Virus-based gene therapy research (1 paper). The work is most often cited by research in Cancer Research (229 citations), Oncology (328 citations), Immunology and Allergy (43 citations), Molecular Biology (470 citations) and Hematology (48 citations). Ari Ristimäki has collaborated with scholars based in Finland, Sweden and Canada. Frequent co-authors include Birgitta Olofsson, Kari Alitalo, Laura Kivinen, Karri Paavonen, Marikki Laiho, Yuji Gunji, Ulf Eriksson, Juha Klefström, Vladimir Joukov and Vijay Kumar. Their work appears in journals such as Journal of Clinical Pathology, Journal of Oral Pathology and Medicine, British Journal of Cancer, Cell Cycle and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.